NIH trial evaluating hydroxychloroquine for COVID-19 underway
The intervention arm will receive hydroxychloroquine in addition to supportive care.
Most recent articles by Diana Ernst, RPh
Abbott’s point-of-care COVID-19 test delivers results within minutes
The Abbott ID NOW COVID-19 tests runs on the ID NOW platform and delivers results within minutes.
FDA takes additional action to expedite availability of COVID-19 tests
The Food and Drug Administration has announced that it will not object to the New York State Department of Health authorizing certain laboratories in New York to start testing patients for coronavirus disease 2019 once the tests have been validated.
FDA, FTC crack down on fraudulent COVID-19 ‘treatments’
Unapproved products are being marketed as coronavirus 2019 cures
